Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
930.70
1.85
(0.20%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Zydus Lifesciences gains on getting USFDA’s final nod for Isotretinoin capsules
>>
Zydus Lifesciences gets USFDA’s final nod for Isotretinoin capsules
>>
Zydus Lifesciences - Quaterly Results
>>
Zydus Lifesciences - Quaterly Results
>>
Zydus Lifesciences - Quaterly Results
>>
Zydus Lifesciences receives EIR from USFDA for Ambernath facility
>>
Zydus Lifesciences rises on getting USFDA’s approval for Glatiramer Acetate Injection
>>
Zydus Lifesciences gets USFDA’s approval for Glatiramer Acetate Injection
>>
Zydus Lifesciences gains on getting USFDA’s final approval for Niacin Extended-Release Tablets
>>
Zydus Lifesciences gets USFDA’s final approval for Niacin Extended-Release Tablets
<<
<
13
14
15
...168
>
>>